Fentanyl drug test (strip) description:

The Fentanyl Drug Test (FTL Drug Test), or The Cortez Diagnostics, Inc. DOA (Drug of Abuse) test, is an immunochromatography based one step in vitro test. The Fentanyl drug test is designed for qualitative determination of fentanyl drug substances in human urine specimen. This assay has not been evaluated in the point of care location and is for use by Healthcare Professionals only.

Fentanyl is a synthetic opioid.  It has the brand names of Sublimaze, Actiq, Durogestic, Fentora and others.  The Fentanyl drug is approximately 100 times more potent than morphine, with 100 micrograms of fentanyl approximately equivalent to 10 mg. of morphine or 75 mg. of meperidine in analgesic activity.  The Fentanyl drug is a potent narcotic analgesic with rapid onset and short duration of action.  Historically, the fentanyl drug has been used to treat chronic breakthrough pain and is commonly used pre-procedures.  Illicit use of pharmaceutical fentanyl drugs first appeared in the mid-1970s.  Because the effects of the fentanyl drug last for only a very short time, it is even more addictive than heroin.  Regular users may become addicted very quickly.  The Fentanyl drug is much more potent than heroin, and tends to produce significantly worse respiratory depression, making it somewhat more dangerous than heroin to users.  Overdose of the fentanyl drug has caused death.  In the United States, the fentanyl drug is classified as a Schedule II controlled substance.

The Fentanyl Drug Testing device is based on the principle of specific immunochemical reaction between antibodies and antigens to analyze particular compounds in human urine specimen. The assay relies on the competition for binding antibody between drug conjugate and free drug which may be present in the urine specimen being tested.  When a fentanyl drug is present in the urine specimen, it competes with drug conjugate for the limited amount of antibody-dye conjugate. When the amount of a Fentanyl drug is equal or more than the cut-off, it will prevent the binding of drug conjugate to the antibody. Therefore, a positive urine specimen on the Fentanyl Drug Test will not show a colored band on the test line zone, indicating a positive result, while the presence of a colored band indicates a negative result.  A control line is present in the test window to work as procedural control. This colored band should always appear on the control line zone if the Fentanyl drug testing device is stored in good condition and the Fentanyl drug test is performed appropriately.

This Fentanyl Drug Test (FTL Drug Test) provides only a preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/ mass spectrometry (GC/MS) has been established as the preferred confirmatory method by the Substance Abuse Mental Health Services Administration (SAMHSA). Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.

The optional built-in Adulteration Test is for validation of urine specimen’s integrity and must not be used for In Vitro diagnostic use. The cutoff level for this Fentanyl Drug Test (FTL Drug Test) is 200 ng/ml of fentanyl.  For customized cutoff level fentanyl drug tests, please contact Customer Service.  This Fentanyl Drug Test (FTL Drug Test) is available in multi-panel, cassette, strip, or cup format.